[JSNP Excellent Presentation Award for AsCNP 2011: improvement of cognitive impairments on withdrawal after repeated methamphetamine by administration of a cannabinoid CB1 receptor antagonist and a COX inhibitor]

Nihon Shinkei Seishin Yakurigaku Zasshi. 2012 Apr;32(2):93-4.
[Article in Japanese]
No abstract available

MeSH terms

  • Animals
  • Awards and Prizes
  • Cognition Disorders / chemically induced
  • Cognition Disorders / drug therapy*
  • Cyclooxygenase Inhibitors / pharmacology*
  • Diclofenac / therapeutic use*
  • Male
  • Methamphetamine / pharmacology*
  • Mice
  • Mice, Inbred ICR
  • Mice, Knockout
  • Piperidines / therapeutic use*
  • Pyrazoles / pharmacology
  • Pyrazoles / therapeutic use*
  • Receptor, Cannabinoid, CB1 / antagonists & inhibitors*
  • Substance Withdrawal Syndrome / drug therapy*

Substances

  • Cyclooxygenase Inhibitors
  • Piperidines
  • Pyrazoles
  • Receptor, Cannabinoid, CB1
  • Diclofenac
  • AM 251
  • Methamphetamine